MAIA Biotechnology (MAIA) Earnings Date & Reports

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of targeted immunotherapies for cancer, with an initial focus on non-small cell lung cancer (NSCLC), which represents the majority of lung cancer cases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

MAIA is expected to report earnings to rise 37.50% to -21 cents per share on August 11

MAIA Biotechnology MAIA Stock Earnings Reports

Q2'26

Est.

$-0.22

Q1'26

Beat

by $0.02

Q4'25

Beat

by $0.03

Q3'25

Missed

by $0.08

Q2'25

Beat

by $0.01

The last earnings report on May 04 showed earnings per share of -15 cents, beating the estimate of -18 cents. With 388.26K shares outstanding, the current market capitalization sits at 87.55M.

View a ticker or compare two or three

Compare

MAIA

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for MAIA